...
首页> 外文期刊>Journal of Pharmacology and Pharmacotherapeutics >Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital
【24h】

Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital

机译:在三级教学医院对两个医疗单位住院患者的药物不良反应进行强化监测

获取原文

摘要

Objective:To detect incidence of adverse drug reactions (ADRs) in hospitalized patients and to assess their causality, seriousness, preventability, and the possible economic impact.Materials and Methods:This was a prospective study carried out in two medical units at a tertiary care, teaching hospital, for about 18 months. All the admitted patients who developed an ADR after admission (group A) or who were admitted primarily for the treatment of an ADR (group B) were included. Descriptive statistics with 95% CI, χ2, χ2 for the trend and kappa test were used.Results:Out of 6601 patients, 140 patients developed 154 ADRs with an incidence of 2.12%. Causality of the majority of the ADRs in group A was ‘possible’ while those in group B was ‘probable’. Among 109 ADRs (34 serious) in group A, 38 were preventable. On the other hand, out of 45 serious ADRs in group B, 19 were preventable. The total cost of 154 ADRs in 140 patients was Rs. 1,49,803 with an average of Rs. 1070 per patient. The preventable cost for 57/154 ADR was Rs. 96,310.Conclusion:Around 2% of the hospital patients develop ADRs. A large number of these ADRs were preventable. A substantial saving can be made if adequate caution is exerted.
机译:目的:检测住院患者的药物不良反应(ADR)发生率,并评估其因果关系,严重性,可预防性以及可能的经济影响。材料与方法:这是在两家医疗机构三级医疗机构中进行的前瞻性研究,教学医院,大约18个月。纳入所有入院后出现ADR的入院患者(A组)或主要接受ADR治疗的入院患者(B组)。结果:在6601例患者中,有140例患者发生了154例ADR,发生率达2.12%,采用描述性统计法对趋势和kappa检验的CI,χ2,χ2为95%。 A组中大多数ADR的因果关系是“可能的”,而B组中大多数ADR的因果关系是“可能的”。在A组的109种ADR(严重的34种)中,有38种是可以预防的。另一方面,在B组的45种严重ADR中,有19种是可以预防的。 140例患者中154例ADR的总费用为Rs。 1,49,803,平均卢比。每位患者1070。 57/154 ADR的可预防成本为卢比。 96,310。结论:约2%的住院患者会发生ADR。这些ADR可以避免。如果采取足够的谨慎措施,则可以节省大量资金。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号